Uncategorized

Boom in GLP-1 Drug Usage When GLP-1 drugs for diabetes and weight loss exploded onto the scene two years ago, patients scrambled to get their hands on them. GLP-1s, which include Ozempic, Wegovy, Mounjaro, and Zepbound, are so popular that it didn’t take long for them to wind up in short supply. According to one

Growing Popularity of ‘Rice-Zempic’ For as long as the market for weight-loss drugs like Ozempic and Wegovy has boomed, people have been on the hunt for non-prescription and cheaper alternatives. Recently, a new natural alternative called ‘Rice-zempic’ has gained popularity on social media, with users claiming it works just as well as the medications. The

Novo Nordisk Stock Rises on China Approval of Wegovy and U.S. Expansion U.S. Expansion and Chinese Approval Boost Novo Nordisk Novo Nordisk saw a rise in its stock price following the approval of its weight loss drug Wegovy in China and the announcement of a $4.1 billion investment to expand its U.S. production capacity. The

New Findings from the Landmark FLOW Clinical Trial Significant Reductions in Kidney Disease Worsening and Cardiovascular Events Semaglutide was associated with significant reductions in worsening kidney disease, cardiovascular events, and all-cause death compared to placebo for adults with type 2 diabetes (T2D) and chronic kidney disease (CKD), regardless of concomitant use of sodium-glucose co-transporter-2 inhibitors

New Research Shows Impact on Addictive Behavior Experts debate whether the study has any pointers for controlling alcohol abuse disorder Blockbuster weight loss drugs like Ozempic and Wegovy may now reduce your craving for alcohol, according to a new study published by Nature Communications. Researchers followed obese individuals for a year after they began taking

Unexpected Pregnancies Reported Among Users Injectable weight-loss and diabetes drugs Ozempic and Wegovy have become household names worldwide. However, amidst the buzz surrounding these medications, reports of a serious side effect soon surfaced. Women described unplanned pregnancies on social media, attributing their ‘Ozempic babies’ to the new drugs. Some women report that they got pregnant

A New Generic Option for Type 2 Diabetes Patients Teva Pharmaceuticals, based in New Jersey and part of Teva Pharmaceutical Industries, has introduced the first generic GLP-1 agonist, liraglutide injections, to the United States market. This move marks a significant milestone as it is the first time a generic version of this drug category is

Novo Nordisk, the company behind the blockbuster weight-loss drug Ozempic, has risen to prominence as Europe’s most valuable company in 2023. However, its high U.S. prices have drawn significant scrutiny, prompting CEO Lars Fruergaard Jørgensen to volunteer to testify before the U.S. Senate. Rising Prominence of Novo Nordisk Novo Nordisk has soared to the mantle

Reflecting on Oprah’s Journey and the New Weight-Loss Drugs I’ve been an Oprah fan since her eponymous show debuted on national television in 1986. Like many viewers, I saw her as a friend. As someone who has spent much of my life struggling with self-acceptance due to being overweight, I especially resonated with her very